glp 1 controversy GLP-1 medicines produce adverse events, predominantly gastrointestinal, transient in most. Yet continues surrounding what AEs are rare but real vs. alleged but not rigorously proven in RCTs or real world data Controversy surrounding diabetes drug, Ozempic,

By helping your body continue producing GLP-1 naturally, this probiotic may help ease that transition and maintain some of the appetite control youve experienced

If you're ready to see the difference that quality and care can make, you can Get Started Today

Potential reduction in depression, cognitive decline, and dementia risk, particularly in older individuals

Typically, branded GLP-1s (Ozempic (semaglutide), Mounjaro (tirzepatide), Zepbound (tirzepatide), Saxenda (liraglutide)) are prescribed for people with obesity (a BMI over 30) or those who are overweight (a BMI over 25) and at least one related condition like diabetes or heart disease

Within a few weeks of pain education, exercise, and the GLP-1 onboard, they were describing something much different, and earlier than I would normally expect: less morning stiffness, fewer flare-ups after longer walks, and a sense that their knee felt less cranky